fda compounding semaglutide enforcement november 2025 news Important Update: Changes to Compounded Availability Compounded "semaglutide" is not FDA-approved

In a pooled analysis of clinical trials assessing patients with heart failure with preserved ejection fraction (HFpEF), including the STEP HFpEF and STEP HFpEF DM trials, as well as in the FLOW and SELECT trials, semaglutide improved New York Heart Association (NYHA) class IIIV symptoms, physical limitations, exercise function, associated with a 30% reduction of N-terminal pro-brain natriuretic peptide and a 31% reduction in the composite endpoint of cardiovascular death and the need for treatment intensification or hospitalization for heart failure-related events (HR 0.69

However, off-label use of drugs such as Ozempic for cosmetic weight loss has surged in popularity, raising concerns about potential misuse and the emergence of substandard and falsified products in the unregulated supply chain

Hove, K

Diabetes Obes Metab (2015) 17(9):84958

In this article, we will explore how these medications work, their effectiveness, and how they are transforming weight loss programs in Pineville, NC

Orskov, C., Holst, J